Anti-PAFAH antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | PAFAH |
| Immunogen: | KLH conjugated synthetic peptide derived from human PAFAH 301-441/441 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:550-1:2100); Immunohistochemistry-Paraffin (1:500-900); Immunofluorescence; Immunocytochemistry (1:200-1:600) |
| Reactivity: | Human, Mouse, Rat, Dog |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Lp-PLA2 |
| PLA2G7 | |
| PAFAH | |
| lipoprotein-associated phospholipase A2 | |
| Platelet-activating factor acetylhydrolase | |
| PAF acetylhydrolase | |
| PAF 2-acylhydrolase | |
| LDL-associated phospholipase A2 | |
| LDL-PLA(2) | |
| 2-acetyl-1-alkylglycerophosphocholine esterase | |
| 1-alkyl-2-acetylglycerophosphocholine esterase | |
| PAFA_HUMAN. |
Show More
Target information
Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids.
Provider
Erpantech Laboratory
